Trial Profile
Efficacy of respiratory quinolones for the treatment of community acquired pneumonia: a randomized controlled trial of moxifloxacin versus garenoxacin.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2012
Price :
$35
*
At a glance
- Drugs Garenoxacin (Primary) ; Moxifloxacin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 13 Nov 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 23 Jul 2011 Actual initiation date (May 2011) as reported by University Hospital Medical Information Network - Japan.
- 23 Jul 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.